- Home
- CVI vs DNLI Comparison
CVI vs DNLI Comparison
Compare CVI & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVI | DNLI |
|---|---|---|
| Founded | 1906 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 2006 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CVI | DNLI |
|---|---|---|
| Price | $36.65 | $23.54 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $28.75 | ★ $34.33 |
| AVG Volume (30 Days) | 893.4K | ★ 1.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | ★ 350.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,162,000,000.00 | N/A |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | N/A | $408.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.62 | $12.58 |
| 52 Week High | $41.67 | $27.30 |
Technical Indicators
Market Signals| Indicator | CVI | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 71.54 | 52.12 |
| Support Level | $33.79 | $18.07 |
| Resistance Level | $41.67 | $27.30 |
| Average True Range (ATR) | 1.64 | 1.15 |
| MACD | 0.44 | -0.09 |
| Stochastic Oscillator | 80.60 | 48.05 |
Price Performance
Historical ComparisonAbout CVI CVR Energy Inc.
CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines, storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.